Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Nat Immunol
    July 2022
  1. HERATI RS, Knorr DA, Vella LA, Silva LV, et al
    PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01274.
    >> Share

    PD-1 blockade unblocks immune responses to vaccination.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01254.
    >> Share

  3. YU D, Walker LSK, Liu Z, Linterman MA, et al
    Targeting TFH cells in human diseases and vaccination: rationale and practice.
    Nat Immunol. 2022 Jul 11. pii: 10.1038/s41590-022-01253.
    >> Share

  4. QI H, Liu B, Wang X, Zhang L, et al
    The humoral response and antibodies against SARS-CoV-2 infection.
    Nat Immunol. 2022;23:1008-1020.
    >> Share

    May 2022
  5. LUSTIG Y, Gonen T, Meltzer L, Gilboa M, et al
    Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
    Nat Immunol. 2022 May 9. pii: 10.1038/s41590-022-01212.
    >> Share

    March 2022

  6. IL-1-mediated inflammation induced by different RNA vaccines is context-specific.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01177.
    >> Share

  7. KOBIYAMA K, Ishii KJ
    Making innate sense of mRNA vaccine adjuvanticity.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01168.
    >> Share

  8. TAHTINEN S, Tong AJ, Himmels P, Oh J, et al
    IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
    Nat Immunol. 2022 Mar 24. pii: 10.1038/s41590-022-01160.
    >> Share

  9. LI C, Lee A, Grigoryan L, Arunachalam PS, et al
    Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
    Nat Immunol. 2022 Mar 14. pii: 10.1038/s41590-022-01163.
    >> Share

    A potential silver lining of delaying the second dose.
    Nat Immunol. 2022;23:349-351.
    >> Share

    February 2022
  11. TOMALKA JA, Suthar MS, Deeks SG, Sekaly RP, et al
    Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Nat Immunol. 2022 Feb 24. pii: 10.1038/s41590-022-01130.
    >> Share

  12. HALL VG, Ferreira VH, Wood H, Ierullo M, et al
    Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
    Nat Immunol. 2022 Feb 3. pii: 10.1038/s41590-021-01126.
    >> Share

    January 2022
  13. EGWANG TG, Owalla TJ, Kemigisha M
    COVID-19 vaccine trials must include helminth-infected cohorts.
    Nat Immunol. 2022 Jan 24. pii: 10.1038/s41590-021-01116.
    >> Share

  14. DOWELL AC, Butler MS, Jinks E, Tut G, et al
    Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
    Nat Immunol. 2022;23:40-49.
    >> Share

    December 2021
    Vaccine thrombosis.
    Nat Immunol. 2021 Dec 22. pii: 10.1038/s41590-021-01111.
    >> Share

    November 2021
  16. BREWER RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al
    BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
    Nat Immunol. 2021 Nov 30. pii: 10.1038/s41590-021-01088.
    >> Share

  17. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    >> Share

  18. NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.
    >> Share

    October 2021
  19. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    >> Share

    September 2021
  20. TOMALKA JA, Pelletier AN, Fourati S, Latif MB, et al
    The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
    Nat Immunol. 2021 Sep 23. pii: 10.1038/s41590-021-01026.
    >> Share

    Hidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunity.
    Nat Immunol. 2021 Sep 23. pii: 10.1038/s41590-021-01018.
    >> Share

  22. WOLYNN T, Hermann C
    Shots heard round the world: better communication holds the key to increasing vaccine acceptance.
    Nat Immunol. 2021;22:1068-1070.
    >> Share

    Intranasal vaccination.
    Nat Immunol. 2021;22:1071.
    >> Share

  24. ALSUWAIDI AR, Al Hosani FI, ElGhazali G, Al-Ramadi BK, et al
    The COVID-19 response in the United Arab Emirates: challenges and opportunities.
    Nat Immunol. 2021;22:1066-1067.
    >> Share

  25. YAO Y, Chen Z, Zhang H, Chen C, et al
    Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.
    Nat Immunol. 2021;22:1127-1139.
    >> Share

    July 2021
  26. CUPOVIC J, Ring SS, Onder L, Colston JM, et al
    Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00969.
    >> Share

  27. DAI L, Xu K, Li J, Huang Q, et al
    Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00966.
    >> Share

  28. MUKHTAR MM, Khogali M
    The accelerating COVID-19 epidemic in Sudan.
    Nat Immunol. 2021;22:797-798.
    >> Share

    April 2021
  29. CHEN SC
    Taiwan's experience in fighting COVID-19.
    Nat Immunol. 2021;22:393-394.
    >> Share

    March 2021
  30. GEOGHEGAN JL, Moreland NJ, Le Gros G, Ussher JE, et al
    New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Nat Immunol. 2021;22:262-263.
    >> Share

  31. MADKAIKAR M, Gupta N, Yadav RM, Bargir UA, et al
    India's crusade against COVID-19.
    Nat Immunol. 2021;22:258-259.
    >> Share

  32. Coping with COVID.
    Nat Immunol. 2021;22:255.
    >> Share

    January 2021
  33. NELDE A, Bilich T, Heitmann JS, Maringer Y, et al
    SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nat Immunol. 2021;22:74-85.
    >> Share

  34. Challenges for the Biden presidency.
    Nat Immunol. 2021;22:1.
    >> Share

  35. DIVANGAHI M, Aaby P, Khader SA, Barreiro LB, et al
    Trained immunity, tolerance, priming and differentiation: distinct immunological processes.
    Nat Immunol. 2021;22:2-6.
    >> Share

    November 2020
  36. BAHAROM F, Ramirez-Valdez RA, Tobin KKS, Yamane H, et al
    Intravenous nanoparticle vaccination generates stem-like TCF1(+) neoantigen-specific CD8(+) T cells.
    Nat Immunol. 2020 Nov 2. pii: 10.1038/s41590-020-00810.
    >> Share

  37. PENG Y, Mentzer AJ, Liu G, Yao X, et al
    Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
    Nat Immunol. 2020;21:1336-1345.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016